← Back to Search

Integrated Care for Mental Health Disorders (PARTNERs Trial)

N/A
Waitlist Available
Led By Benoit H Mulsant, MD
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

PARTNERs Trial Summary

This trial will compare a new mental health care model to usual care to see if symptoms and quality of life improve.

Who is the study for?
This trial is for adults over 18 who are suspected of having depression, anxiety, or alcohol-related issues and are under the care of a primary care provider at participating organizations. They must be able to communicate in English by phone and give informed consent. People with certain mental health conditions, substance abuse (excluding alcohol), cognitive impairment, high suicide risk, physical instability requiring hospitalization, or expected to die within 6 months cannot join.Check my eligibility
What is being tested?
The study tests an integrated care model where Mental Health Technicians use specialized software to help primary care providers manage mental health via telephone. It's compared against enhanced usual care to see if it better starts treatment, reduces symptom severity, and improves life quality/functioning.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like telephone-based support and computer-aided management rather than drugs or medical procedures, traditional side effects aren't applicable. However, participants may experience discomfort discussing personal issues.

PARTNERs Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Severity of depressive symptoms, as measured with PHQ-9 during phone interviews at 4, 8, and 12 months
Secondary outcome measures
Initiation or change in antidepressant medication documented in the health record at the 4-, 8-, and 12-month follow up
Severity of anxiety symptoms during the past 2 weeks and number of drinks during the past week
Time to initiation of first specific treatment for depression by the primary care provider
Other outcome measures
Changes on the Veterans Rand-12 (VR-12) Health Survey
Proportion of subjects receiving treatment for depression, anxiety, an alcohol use disorder or at-risk drinking
Rates of depression remission, depression response, anxiety remission, anxiety response, and decrease in alcohol use to the point where it meets the guidelines for safe drinking, remaining stable, or worsening.

PARTNERs Trial Design

2Treatment groups
Experimental Treatment
Group I: Intervention: Mental Health TechnicianExperimental Treatment1 Intervention
The subject's Primary Care Provider will receive results of baseline, four, eight, and twelve month assessments examining the subject's symptoms of depression, anxiety, and other mental health problems, use of alcohol and illicit substances, physical pain, and quality of life and recommendations for treatment. Over a 3-12 months period, the Intervention group will receive a brief, telephone-based intervention by a Mental Health Technician that will focus on monitoring symptoms, treatment adherence, and providing psychoeducation.
Group II: Enhanced Usual CareExperimental Treatment1 Intervention
This group will receive Enhanced Usual Care. The subject's Primary Care Provider will receive results of baseline, four, eight, and twelve month assessments examining the subject's symptoms of depression, anxiety, and other mental health problems, use of alcohol and illicit substances, physical pain, and quality of life . If the subjects primary care provider chooses, they can use this information to construct the subject's treatment plan.

Find a Location

Who is running the clinical trial?

CAMH FoundationOTHER
2 Previous Clinical Trials
278 Total Patients Enrolled
Centre for Addiction and Mental HealthLead Sponsor
356 Previous Clinical Trials
80,809 Total Patients Enrolled
85 Trials studying Depression
18,616 Patients Enrolled for Depression
Capital Solution Design LLCUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment period for this research still open?

"Data hosted on clinicaltrials.gov shows that this trial, which was first posted in November of 2014 and last updated on October 18th 2023 is no longer seeking enrollees. Luckily, 1731 other trials are currently accepting patients for participation."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
CAMH PARTNERs Integrated Care Study
Benoit Mulsant 2014. "CAMH PARTNERs Integrated Care Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02345122.
All > Depression > Treatment Resistant Depression
~61 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top